Federal Pharmaceutical (03933.HK): Sodium Amoxicillin and Potassium Clavulanate for Injection Passed Consistency Evaluation.

The Cheung Kong Financial APP announced that Federal Pharmaceutical (03933.HK) released a statement, stating that the injection of amoxicillin sodium clavulanate potassium (specifications: 0.6g, 1.2g) declared by its wholly-owned subsidiary, Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch, has been approved by the China National Medical Products Administration and passed the generic drug quality and efficacy consistency evaluation.